Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 4 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 2 |
Pissara et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 4 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 3 |
GO:0005737 | cytoplasm | 2 | 3 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: E9AXN8
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 19 |
GO:0006793 | phosphorus metabolic process | 3 | 19 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 19 |
GO:0006807 | nitrogen compound metabolic process | 2 | 19 |
GO:0008152 | metabolic process | 1 | 19 |
GO:0009987 | cellular process | 1 | 19 |
GO:0016310 | phosphorylation | 5 | 19 |
GO:0019538 | protein metabolic process | 3 | 19 |
GO:0036211 | protein modification process | 4 | 19 |
GO:0043170 | macromolecule metabolic process | 3 | 19 |
GO:0043412 | macromolecule modification | 4 | 19 |
GO:0044237 | cellular metabolic process | 2 | 19 |
GO:0044238 | primary metabolic process | 2 | 19 |
GO:0071704 | organic substance metabolic process | 2 | 19 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 19 |
GO:0006810 | transport | 3 | 3 |
GO:0006897 | endocytosis | 5 | 3 |
GO:0007165 | signal transduction | 2 | 3 |
GO:0016192 | vesicle-mediated transport | 4 | 3 |
GO:0018105 | peptidyl-serine phosphorylation | 6 | 3 |
GO:0018193 | peptidyl-amino acid modification | 5 | 3 |
GO:0018209 | peptidyl-serine modification | 6 | 3 |
GO:0050789 | regulation of biological process | 2 | 3 |
GO:0050794 | regulation of cellular process | 3 | 3 |
GO:0051179 | localization | 1 | 3 |
GO:0051234 | establishment of localization | 2 | 3 |
GO:0065007 | biological regulation | 1 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 19 |
GO:0003824 | catalytic activity | 1 | 19 |
GO:0004672 | protein kinase activity | 3 | 19 |
GO:0005488 | binding | 1 | 19 |
GO:0005524 | ATP binding | 5 | 19 |
GO:0016301 | kinase activity | 4 | 19 |
GO:0016740 | transferase activity | 2 | 19 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 19 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 19 |
GO:0017076 | purine nucleotide binding | 4 | 19 |
GO:0030554 | adenyl nucleotide binding | 5 | 19 |
GO:0032553 | ribonucleotide binding | 3 | 19 |
GO:0032555 | purine ribonucleotide binding | 4 | 19 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 19 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 19 |
GO:0036094 | small molecule binding | 2 | 19 |
GO:0043167 | ion binding | 2 | 19 |
GO:0043168 | anion binding | 3 | 19 |
GO:0097159 | organic cyclic compound binding | 2 | 19 |
GO:0097367 | carbohydrate derivative binding | 2 | 19 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 19 |
GO:1901265 | nucleoside phosphate binding | 3 | 19 |
GO:1901363 | heterocyclic compound binding | 2 | 19 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 489 | 493 | PF00656 | 0.547 |
CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.332 |
CLV_NRD_NRD_1 | 266 | 268 | PF00675 | 0.388 |
CLV_NRD_NRD_1 | 344 | 346 | PF00675 | 0.506 |
CLV_NRD_NRD_1 | 412 | 414 | PF00675 | 0.786 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.522 |
CLV_PCSK_KEX2_1 | 172 | 174 | PF00082 | 0.321 |
CLV_PCSK_KEX2_1 | 266 | 268 | PF00082 | 0.388 |
CLV_PCSK_KEX2_1 | 344 | 346 | PF00082 | 0.472 |
CLV_PCSK_KEX2_1 | 352 | 354 | PF00082 | 0.487 |
CLV_PCSK_KEX2_1 | 412 | 414 | PF00082 | 0.786 |
CLV_PCSK_KEX2_1 | 450 | 452 | PF00082 | 0.528 |
CLV_PCSK_KEX2_1 | 456 | 458 | PF00082 | 0.572 |
CLV_PCSK_KEX2_1 | 506 | 508 | PF00082 | 0.554 |
CLV_PCSK_PC1ET2_1 | 352 | 354 | PF00082 | 0.502 |
CLV_PCSK_PC1ET2_1 | 450 | 452 | PF00082 | 0.525 |
CLV_PCSK_PC1ET2_1 | 456 | 458 | PF00082 | 0.568 |
CLV_PCSK_PC1ET2_1 | 506 | 508 | PF00082 | 0.554 |
CLV_PCSK_PC7_1 | 348 | 354 | PF00082 | 0.413 |
CLV_PCSK_SKI1_1 | 177 | 181 | PF00082 | 0.434 |
CLV_PCSK_SKI1_1 | 201 | 205 | PF00082 | 0.345 |
CLV_PCSK_SKI1_1 | 21 | 25 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 245 | 249 | PF00082 | 0.362 |
CLV_PCSK_SKI1_1 | 298 | 302 | PF00082 | 0.468 |
CLV_PCSK_SKI1_1 | 306 | 310 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 320 | 324 | PF00082 | 0.442 |
CLV_PCSK_SKI1_1 | 344 | 348 | PF00082 | 0.418 |
CLV_PCSK_SKI1_1 | 507 | 511 | PF00082 | 0.641 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.480 |
DEG_APCC_DBOX_1 | 172 | 180 | PF00400 | 0.406 |
DEG_APCC_DBOX_1 | 266 | 274 | PF00400 | 0.442 |
DEG_SCF_FBW7_2 | 307 | 313 | PF00400 | 0.262 |
DOC_CKS1_1 | 307 | 312 | PF01111 | 0.406 |
DOC_CKS1_1 | 417 | 422 | PF01111 | 0.553 |
DOC_CYCLIN_RxL_1 | 327 | 335 | PF00134 | 0.430 |
DOC_CYCLIN_RxL_1 | 348 | 357 | PF00134 | 0.511 |
DOC_CYCLIN_yCln2_LP_2 | 382 | 388 | PF00134 | 0.586 |
DOC_MAPK_gen_1 | 213 | 221 | PF00069 | 0.374 |
DOC_MAPK_gen_1 | 234 | 241 | PF00069 | 0.332 |
DOC_MAPK_gen_1 | 352 | 358 | PF00069 | 0.580 |
DOC_MAPK_gen_1 | 42 | 52 | PF00069 | 0.418 |
DOC_MAPK_MEF2A_6 | 43 | 52 | PF00069 | 0.416 |
DOC_PP1_RVXF_1 | 226 | 232 | PF00149 | 0.406 |
DOC_PP1_RVXF_1 | 328 | 335 | PF00149 | 0.426 |
DOC_PP2B_LxvP_1 | 356 | 359 | PF13499 | 0.406 |
DOC_PP2B_LxvP_1 | 382 | 385 | PF13499 | 0.566 |
DOC_PP4_FxxP_1 | 417 | 420 | PF00568 | 0.682 |
DOC_PP4_FxxP_1 | 510 | 513 | PF00568 | 0.555 |
DOC_USP7_MATH_1 | 102 | 106 | PF00917 | 0.559 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.589 |
DOC_USP7_MATH_1 | 376 | 380 | PF00917 | 0.733 |
DOC_USP7_MATH_1 | 386 | 390 | PF00917 | 0.684 |
DOC_USP7_MATH_1 | 395 | 399 | PF00917 | 0.616 |
DOC_USP7_MATH_1 | 502 | 506 | PF00917 | 0.719 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.477 |
DOC_USP7_UBL2_3 | 316 | 320 | PF12436 | 0.592 |
DOC_USP7_UBL2_3 | 51 | 55 | PF12436 | 0.512 |
DOC_WW_Pin1_4 | 106 | 111 | PF00397 | 0.536 |
DOC_WW_Pin1_4 | 306 | 311 | PF00397 | 0.427 |
DOC_WW_Pin1_4 | 391 | 396 | PF00397 | 0.655 |
DOC_WW_Pin1_4 | 416 | 421 | PF00397 | 0.616 |
DOC_WW_Pin1_4 | 509 | 514 | PF00397 | 0.625 |
LIG_14-3-3_CanoR_1 | 129 | 137 | PF00244 | 0.450 |
LIG_14-3-3_CanoR_1 | 172 | 177 | PF00244 | 0.371 |
LIG_14-3-3_CanoR_1 | 330 | 335 | PF00244 | 0.428 |
LIG_14-3-3_CanoR_1 | 353 | 359 | PF00244 | 0.402 |
LIG_14-3-3_CanoR_1 | 399 | 404 | PF00244 | 0.767 |
LIG_14-3-3_CanoR_1 | 412 | 416 | PF00244 | 0.584 |
LIG_14-3-3_CanoR_1 | 478 | 484 | PF00244 | 0.637 |
LIG_14-3-3_CanoR_1 | 507 | 513 | PF00244 | 0.515 |
LIG_Actin_WH2_2 | 269 | 284 | PF00022 | 0.415 |
LIG_AP2alpha_1 | 33 | 37 | PF02296 | 0.392 |
LIG_APCC_ABBAyCdc20_2 | 196 | 202 | PF00400 | 0.347 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.529 |
LIG_BRCT_BRCA1_1 | 271 | 275 | PF00533 | 0.291 |
LIG_BRCT_BRCA1_1 | 364 | 368 | PF00533 | 0.493 |
LIG_BRCT_BRCA1_1 | 413 | 417 | PF00533 | 0.722 |
LIG_BRCT_BRCA1_1 | 499 | 503 | PF00533 | 0.541 |
LIG_deltaCOP1_diTrp_1 | 442 | 448 | PF00928 | 0.512 |
LIG_FHA_1 | 297 | 303 | PF00498 | 0.378 |
LIG_FHA_1 | 509 | 515 | PF00498 | 0.697 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.770 |
LIG_FHA_2 | 307 | 313 | PF00498 | 0.356 |
LIG_FHA_2 | 428 | 434 | PF00498 | 0.662 |
LIG_FHA_2 | 493 | 499 | PF00498 | 0.713 |
LIG_FHA_2 | 9 | 15 | PF00498 | 0.624 |
LIG_GBD_Chelix_1 | 273 | 281 | PF00786 | 0.226 |
LIG_LIR_Apic_2 | 414 | 420 | PF02991 | 0.722 |
LIG_LIR_Gen_1 | 148 | 158 | PF02991 | 0.427 |
LIG_LIR_Gen_1 | 272 | 281 | PF02991 | 0.320 |
LIG_LIR_Gen_1 | 339 | 347 | PF02991 | 0.389 |
LIG_LIR_Gen_1 | 442 | 453 | PF02991 | 0.557 |
LIG_LIR_Nem_3 | 227 | 233 | PF02991 | 0.327 |
LIG_LIR_Nem_3 | 272 | 278 | PF02991 | 0.355 |
LIG_LIR_Nem_3 | 284 | 290 | PF02991 | 0.359 |
LIG_LIR_Nem_3 | 32 | 36 | PF02991 | 0.478 |
LIG_LIR_Nem_3 | 321 | 325 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 339 | 343 | PF02991 | 0.302 |
LIG_LIR_Nem_3 | 442 | 448 | PF02991 | 0.522 |
LIG_LIR_Nem_3 | 66 | 72 | PF02991 | 0.461 |
LIG_LYPXL_yS_3 | 59 | 62 | PF13949 | 0.502 |
LIG_MYND_3 | 428 | 432 | PF01753 | 0.544 |
LIG_Pex14_2 | 33 | 37 | PF04695 | 0.479 |
LIG_PTB_Apo_2 | 27 | 34 | PF02174 | 0.413 |
LIG_SH2_CRK | 340 | 344 | PF00017 | 0.416 |
LIG_SH2_CRK | 69 | 73 | PF00017 | 0.444 |
LIG_SH2_STAP1 | 441 | 445 | PF00017 | 0.519 |
LIG_SH2_STAP1 | 64 | 68 | PF00017 | 0.410 |
LIG_SH2_STAT5 | 144 | 147 | PF00017 | 0.383 |
LIG_SH2_STAT5 | 169 | 172 | PF00017 | 0.324 |
LIG_SH2_STAT5 | 192 | 195 | PF00017 | 0.413 |
LIG_SH2_STAT5 | 220 | 223 | PF00017 | 0.374 |
LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.373 |
LIG_SH2_STAT5 | 279 | 282 | PF00017 | 0.378 |
LIG_SH2_STAT5 | 325 | 328 | PF00017 | 0.405 |
LIG_SH3_2 | 513 | 518 | PF14604 | 0.507 |
LIG_SH3_3 | 134 | 140 | PF00018 | 0.482 |
LIG_SH3_3 | 375 | 381 | PF00018 | 0.729 |
LIG_SH3_3 | 510 | 516 | PF00018 | 0.634 |
LIG_SUMO_SIM_par_1 | 178 | 184 | PF11976 | 0.464 |
LIG_SUMO_SIM_par_1 | 396 | 408 | PF11976 | 0.563 |
LIG_TRAF2_1 | 310 | 313 | PF00917 | 0.483 |
LIG_UBA3_1 | 346 | 352 | PF00899 | 0.386 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.537 |
MOD_CK1_1 | 131 | 137 | PF00069 | 0.444 |
MOD_CK1_1 | 175 | 181 | PF00069 | 0.369 |
MOD_CK1_1 | 402 | 408 | PF00069 | 0.773 |
MOD_CK1_1 | 411 | 417 | PF00069 | 0.612 |
MOD_CK1_1 | 477 | 483 | PF00069 | 0.728 |
MOD_CK1_1 | 63 | 69 | PF00069 | 0.413 |
MOD_CK1_1 | 92 | 98 | PF00069 | 0.570 |
MOD_CK2_1 | 306 | 312 | PF00069 | 0.369 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.709 |
MOD_Cter_Amidation | 350 | 353 | PF01082 | 0.333 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.522 |
MOD_GlcNHglycan | 364 | 367 | PF01048 | 0.668 |
MOD_GlcNHglycan | 500 | 503 | PF01048 | 0.649 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.540 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.712 |
MOD_GSK3_1 | 302 | 309 | PF00069 | 0.320 |
MOD_GSK3_1 | 328 | 335 | PF00069 | 0.321 |
MOD_GSK3_1 | 386 | 393 | PF00069 | 0.699 |
MOD_GSK3_1 | 395 | 402 | PF00069 | 0.724 |
MOD_GSK3_1 | 404 | 411 | PF00069 | 0.584 |
MOD_GSK3_1 | 467 | 474 | PF00069 | 0.625 |
MOD_GSK3_1 | 498 | 505 | PF00069 | 0.742 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.550 |
MOD_N-GLC_1 | 106 | 111 | PF02516 | 0.529 |
MOD_N-GLC_1 | 29 | 34 | PF02516 | 0.414 |
MOD_N-GLC_1 | 371 | 376 | PF02516 | 0.621 |
MOD_N-GLC_1 | 92 | 97 | PF02516 | 0.535 |
MOD_N-GLC_2 | 168 | 170 | PF02516 | 0.313 |
MOD_N-GLC_2 | 367 | 369 | PF02516 | 0.520 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.503 |
MOD_NEK2_1 | 247 | 252 | PF00069 | 0.384 |
MOD_NEK2_1 | 262 | 267 | PF00069 | 0.345 |
MOD_NEK2_1 | 281 | 286 | PF00069 | 0.360 |
MOD_NEK2_1 | 332 | 337 | PF00069 | 0.440 |
MOD_NEK2_1 | 354 | 359 | PF00069 | 0.546 |
MOD_NEK2_1 | 368 | 373 | PF00069 | 0.696 |
MOD_NEK2_1 | 491 | 496 | PF00069 | 0.760 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.732 |
MOD_PIKK_1 | 332 | 338 | PF00454 | 0.545 |
MOD_PIKK_1 | 41 | 47 | PF00454 | 0.332 |
MOD_PIKK_1 | 467 | 473 | PF00454 | 0.495 |
MOD_PK_1 | 399 | 405 | PF00069 | 0.566 |
MOD_PKA_1 | 172 | 178 | PF00069 | 0.358 |
MOD_PKA_1 | 234 | 240 | PF00069 | 0.415 |
MOD_PKA_2 | 128 | 134 | PF00069 | 0.491 |
MOD_PKA_2 | 172 | 178 | PF00069 | 0.344 |
MOD_PKA_2 | 281 | 287 | PF00069 | 0.419 |
MOD_PKA_2 | 411 | 417 | PF00069 | 0.727 |
MOD_PKA_2 | 477 | 483 | PF00069 | 0.688 |
MOD_Plk_1 | 131 | 137 | PF00069 | 0.437 |
MOD_Plk_1 | 405 | 411 | PF00069 | 0.654 |
MOD_Plk_1 | 491 | 497 | PF00069 | 0.631 |
MOD_Plk_1 | 92 | 98 | PF00069 | 0.521 |
MOD_Plk_2-3 | 492 | 498 | PF00069 | 0.491 |
MOD_Plk_4 | 131 | 137 | PF00069 | 0.432 |
MOD_Plk_4 | 175 | 181 | PF00069 | 0.468 |
MOD_Plk_4 | 399 | 405 | PF00069 | 0.566 |
MOD_Plk_4 | 92 | 98 | PF00069 | 0.512 |
MOD_ProDKin_1 | 106 | 112 | PF00069 | 0.536 |
MOD_ProDKin_1 | 306 | 312 | PF00069 | 0.427 |
MOD_ProDKin_1 | 391 | 397 | PF00069 | 0.656 |
MOD_ProDKin_1 | 416 | 422 | PF00069 | 0.615 |
MOD_ProDKin_1 | 509 | 515 | PF00069 | 0.627 |
MOD_SUMO_for_1 | 203 | 206 | PF00179 | 0.364 |
MOD_SUMO_for_1 | 50 | 53 | PF00179 | 0.439 |
MOD_SUMO_rev_2 | 35 | 44 | PF00179 | 0.350 |
MOD_SUMO_rev_2 | 454 | 463 | PF00179 | 0.567 |
MOD_SUMO_rev_2 | 63 | 68 | PF00179 | 0.391 |
TRG_DiLeu_BaEn_2 | 270 | 276 | PF01217 | 0.313 |
TRG_DiLeu_BaLyEn_6 | 396 | 401 | PF01217 | 0.564 |
TRG_ENDOCYTIC_2 | 151 | 154 | PF00928 | 0.407 |
TRG_ENDOCYTIC_2 | 230 | 233 | PF00928 | 0.285 |
TRG_ENDOCYTIC_2 | 340 | 343 | PF00928 | 0.385 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.502 |
TRG_ENDOCYTIC_2 | 69 | 72 | PF00928 | 0.448 |
TRG_ER_diArg_1 | 172 | 174 | PF00400 | 0.323 |
TRG_ER_diArg_1 | 343 | 345 | PF00400 | 0.491 |
TRG_NLS_Bipartite_1 | 42 | 59 | PF00514 | 0.365 |
TRG_NLS_MonoExtN_4 | 54 | 59 | PF00514 | 0.417 |
TRG_Pf-PMV_PEXEL_1 | 344 | 349 | PF00026 | 0.467 |
TRG_Pf-PMV_PEXEL_1 | 70 | 74 | PF00026 | 0.427 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3F5 | Leptomonas seymouri | 39% | 100% |
A0A1X0NZS9 | Trypanosomatidae | 45% | 100% |
A0A3Q8IJ66 | Leishmania donovani | 45% | 100% |
A0A3R7K1Y6 | Trypanosoma rangeli | 28% | 78% |
A0A3S7WZA2 | Leishmania donovani | 93% | 100% |
A0A422NL83 | Trypanosoma rangeli | 49% | 100% |
A4HEI6 | Leishmania braziliensis | 76% | 98% |
A4HFV0 | Leishmania braziliensis | 31% | 93% |
A4HMD1 | Leishmania braziliensis | 45% | 100% |
A4I1K4 | Leishmania infantum | 93% | 100% |
A4IAZ8 | Leishmania infantum | 45% | 100% |
C9ZK43 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
C9ZM31 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 75% |
E9B5Y1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 45% | 100% |
Q4Q6U1 | Leishmania major | 42% | 100% |
Q4Q9T3 | Leishmania major | 90% | 97% |
Q8BN21 | Mus musculus | 27% | 100% |
Q9NHE1 | Leishmania major | 45% | 100% |